Enhancement of therapeutic protein in vivo activities through glycoengineering (Q34180647)

31 July 2017

title

Enhancement of therapeutic protein in vivo activities through glycoengineering (English)

1 reference

31 July 2017

Steve Elliott

1

1 reference

31 July 2017

Tony Lorenzini

2

1 reference

31 July 2017

Sheilah Asher

3

1 reference

31 July 2017

Ken Aoki

4

1 reference

31 July 2017

David Brankow

5

1 reference

31 July 2017

Lynette Buck

6

1 reference

31 July 2017

Leigh Busse

7

1 reference

31 July 2017

David Chang

8

1 reference

31 July 2017

Janis Fuller

9

1 reference

31 July 2017

James Grant

10

1 reference

31 July 2017

Natasha Hernday

11

1 reference

31 July 2017

Martha Hokum

12

1 reference

31 July 2017

Sylvia Hu

13

1 reference

31 July 2017

Andrew Knudten

14

1 reference

31 July 2017

Nancy Levin

15

1 reference

31 July 2017

Renee Komorowski

16

1 reference

31 July 2017

Frank Martin

17

1 reference

31 July 2017

Rachell Navarro

18

1 reference

31 July 2017

Timothy Osslund

19

1 reference

31 July 2017

Gary Rogers

20

1 reference

31 July 2017

Norma Rogers

21

1 reference

31 July 2017

Geri Trail

22

1 reference

31 July 2017

Joan Egrie

23

1 reference

31 July 2017

publication date

3 March 2003

1 reference

31 July 2017

1 reference

31 July 2017

volume

21

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

414-421

1 reference

An erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological properties

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Human erythropoietin dimers with markedly enhanced in vivo activity

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Plasminogen activator inhibitor-1 fused with erythropoietin (EPO) mimetic peptide (EMP) enhances the EPO activity of EMP

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Prolonged in vivo anticoagulant activity of a hirudin-albumin fusion protein secreted from Pichia pastoris.

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

The rhGM-CSF-EPO hybrid protein MEN 11300 induces anti-EPO antibodies and severe anaemia in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Structural requirements for protein N-glycosylation. Influence of acceptor peptides on cotranslational glycosylation of yeast invertase and site-directed mutagenesis around a sequon sequence

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Differences between Asn-Xaa-Thr-containing peptides: a comparison of solution conformation and substrate behavior with oligosaccharyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Erythropoietin: gene cloning, protein structure, and biological properties

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Cloning and expression of the human erythropoietin gene

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl.

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Efficiency of signalling through cytokine receptors depends critically on receptor orientation

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

NMR structure of human erythropoietin and a comparison with its receptor bound conformation

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Use of N-glycanase to release asparagine-linked oligosaccharides for structural analysis

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Structural requirements for addition of O-linked carbohydrate to recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Development and characterization of novel erythropoiesis stimulating protein (NESP)

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Once-weekly compared with three-times-weekly subcutaneous epoetin beta: results from a randomized, multicenter, therapeutic-equivalence study.

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Novel erythropoiesis stimulating protein for managing the anemia of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP).

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Role of glycosylation on the secretion and biological activity of erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Activation of the erythropoietin (EPO) receptor by bivalent anti-EPO receptor antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Identification and expression cloning of a leptin receptor, OB-R

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily

1 reference

https://api.crossref.org/works/10.1038%2FNBT799

7 January 2021

Identifiers

DOI

10.1038/NBT799

1 reference

31 July 2017

1 reference